Technical Advisory Group on COVID-19 Mortality Assessment
Introduction
In the context of the collaboration between the World Health Organization (WHO) and the United Nations Department of Economic and Social Affairs (UN DESA), the Technical Advisory Group on COVID-19 Mortality Assessment is established in accordance with these Terms of Reference to serve as a broad scientific and strategic platform to facilitate the exchange of knowledge and application of methods on COVID-19 mortality.
The Technical Advisory Group (the “TAG”) will act as an advisory body to WHO and UN DESA in this area of work. Its primary role will be to advise and support efforts to assist WHO and UN Member States to obtain accurate estimates of numbers of deaths attributable to the direct and indirect impacts of the pandemic.
Objectives
The Technical Advisory Group (TAG) on COVID-19 Mortality Assessment, jointly established by WHO and UN DESA, aims to focus on developing methods and gathering data to estimate the total numbers of deaths attributable to the COVID-19 pandemic and for assessing the direct and indirect impacts of the pandemic on mortality by age and sex at the national, regional and global levels.
The TAG now operates as a single working Group, which role is to advise and, as appropriate, assist WHO and UN DESA in estimating global mortality attributable to the COVID-19 pandemic, for inclusion in future editions of the World Population Prospects and the World Health Statistics reports to be published in 2021 and thereafter.
The working group employs a two-track approach : (a) short-term guidance and assistance in the production of mortality estimates by age and sex for all countries and areas before and during the pandemic period to identify excess mortality attributable to the COVID-19 pandemic; and (b) a strategy for generating authoritative, transparent and well-documented estimates of global mortality before and during the pandemic, using all information available on deaths from COVID-19 and other causes to quantify the excess mortality directly or indirectly attributable to the pandemic.Methods for estimating the excess mortality associated with the COVID-19 pandemic
Methods for estimating the excess mortality associated...
Member biographies
#= POSITION ? POSITION + "
" : "" # #= DEPARTMENT ? DEPARTMENT + "
" : "" # #= INSTITUTION ? INSTITUTION + "
" : "" #
": "" #
#= POSITION ? POSITION + "
" : "" # #= DEPARTMENT ? DEPARTMENT + "
" : "" # #= INSTITUTION ? INSTITUTION + "
" : "" #
": "" #
#= POSITION ? POSITION + "
" : "" # #= DEPARTMENT ? DEPARTMENT + "
" : "" # #= INSTITUTION ? INSTITUTION + "
" : "" #
": "" #
#= POSITION ? POSITION + "
" : "" # #= DEPARTMENT ? DEPARTMENT + "
" : "" # #= INSTITUTION ? INSTITUTION + "
" : "" #
": "" #
#= POSITION ? POSITION + "
" : "" # #= DEPARTMENT ? DEPARTMENT + "
" : "" # #= INSTITUTION ? INSTITUTION + "
" : "" #
": "" #
Observers
Enrique Acosta
Research Scientist
Laboratory of Population Health
Max Planck Institute for Demographic Research
Afshin Ashofteh
Data Scientist and Statistician, Assistant Professor
NOVA Information Management School (NOVA IMS) of NOVA University of Lisbon,
and Research Fellow, Statistics Portugal
(INE)
Mirza Balaj
CHAIN Research Coordinator
Department of Sociology and Politcal Science
Norwegian University of Science and Technology
Helena Cruz-Castanheira
Population Affairs Officer
UNECLAC
Samantha Dolan
Senior Programme Officer Surveillance and Epidemiology
BMGF
Scott Dowell
Deputy Director for Surveillance and Epidemiology
BMGF
Eric Feigl-Ding
Chief Health Economist, Microclinic International
Senior Fellow, Federation of American Scientists
Andres Gutierrez Rojas
Statistician
Statistics Division
Economic Commission for Latin America and the Caribbean
Alamgir Hossen
Statistician and focal point officer
Sustainable Development Goal Cell
Bangladesh Bureau of Statistics
Ilya Kashnitsky
Assistant Professor
Center on Population Dynamics
University of Southern Denmark
Arup Kumar Das
Public Health Specialist
Public Health Foundation of India
Stefan Ma
Deputy Director
Statistics and Research
Ministry of Health, Singapore
Farnaz Malik
Senior Program Officer
Vital Strategies
Janet Mucheru
CEO
Civil Registration Services , Kenya
Petra Nahmias
Chief of Population and Social Statistics Section
UNESCAP
Martin Nyahoda
Deputy Registrar-General
National Registration, passport and Citizenship, Zambia
Naama Rotem
Data Analyst
4M Analytics, Israel
Estifanos Shargie
Focal point for CRVS
MECA Team, The Global Fund
Romesh Silva
Technical specialist
UNFPA
Sondre Solstad
Data Journalist and Analyst
The Economist
Andrew Stokes
Department of Global Health
Boston University School of Public Health USA
Terje Andreas Eikemo
Director and Leader, CHAIN
Department of Sociology and Politcal Science
Norwegian University of Science and Technology
Danzhen You
Lead Statistician
UNICEF
David Zezai
Biostatistician
Global Health 5050
Please contact the Secretariat should you wish to apply / express your interest to act as an observer to the TAG : [email protected], [email protected]
Disclaimer
In order to enhance its management of Conflicts of Interest as well as strengthen public trust and transparency in connection with WHO meetings involving the provision of technical/normative advice, the names and brief biographies of individuals (“Published Information” ) being considered for participation in such meetings are disclosed for public notice and comment.
The Published Information is provided by the experts themselves and is the sole responsibility of the individuals concerned. WHO is not responsible for the accuracy, veracity and completeness of the Published Information provided. Furthermore,
in no event will WHO be responsible or liable for damages in relation to the use of, and reliance upon, the Published Information.
The comments received by WHO through the public notice and comment process are treated confidentially and their receipt will be acknowledged through a generic email notification to the sender. Comments and perceptions brought to the knowledge
of WHO through this process are an integral component of WHO’s conflict of interest assessment policy and are carefully reviewed. WHO reserves the right to discuss information received through this process with the relevant expert with no
attribution to the provider of such information. Upon review and assessment of the information received through this process, WHO, in its sole discretion, may take appropriate management action in accordance with its policies.
The participation of an expert in a WHO meeting does not imply that they are endorsed or recommended by the World Health Organization nor does it create a binding relationship between the expert and WHO.
The list of participating experts, a summary of relevant interests disclosed by such experts, and any appropriate mitigation measures taken by WHO relating to the management of conflicts of interests, will be reported publicly in accordance with WHO practice.